Literature DB >> 16322400

Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling.

A S Rao1, N Kremenevskaja, J Resch, G Brabant.   

Abstract

BACKGROUND: Lithium, clinically used in the treatment of bipolar disorders, is well known to induce thyroid growth. However, the mechanism involved is only incompletely characterized. Although it is conventionally believed that thyroid proliferation depends on the thyroid-stimulating hormone (TSH)/cAMP/cAMP response element binding protein (CREB) pathway, recent data indicate that Wnt/beta-catenin signalling may be of critical importance. In other cell types lithium activates canonical Wnt signalling by GSK-3beta inhibition, which in turn stabilizes cytosolic free beta-catenin. Here we investigated the potential modulation of Wnt/beta-catenin signalling under lithium treatment in primary and neoplastic human thyrocytes.
METHODS: Primary (S18) and neoplastic (NPA, FTC133) thyrocytes treated with and without LiCl were analysed using Western blotting, immunoprecipitation, reporter-gene assay, MTT proliferation assay and transfection studies.
RESULTS: LiCl dose-dependently inhibited GSK-3beta, stabilized free beta-catenin and inhibited beta-catenin degradation. Furthermore, LiCl altered the assembly of adherens junction by upregulating the E-cad-herin repressor, Snail, and downregulated E-cadherin expression. At a dose of 5 mM, LiCl significantly increased the proliferative potency of thyrocytes, which appeared to be mediated by beta-catenin, since nuclear beta-catenin stimulated T-cell factor/lymphoid enhancer factor (TCF/LEF)-mediated transcription and upregulated downstream targets like cyclin D1. To characterize the specificity of Wnt/beta-catenin-driven thyrocyte proliferation, we transfected primary thyrocytes and FTC133 cells with dominant negative TCF4 to block Wnt-dependent pathways or with dominant negative CREB to inhibit the TSH/cAMP cascade. In cells transfected with dominant negative CREB lithium-stimulated proliferation was unchanged whereas blocking Wnt/beta-catenin by dominant negative TCF4 reduced proliferation by approx. 50%.
CONCLUSION: Our data indicate that Wnt/beta-catenin signalling is of major importance in the control of lithium-dependent thyrocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322400     DOI: 10.1530/eje.1.02038

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  35 in total

Review 1.  Does lithium prevent Alzheimer's disease?

Authors:  Orestes V Forlenza; Vanessa J de Paula; Rodrigo Machado-Vieira; Breno S Diniz; Wagner F Gattaz
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

Review 2.  Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases.

Authors:  Sebastian Reuter; Hendrik Beckert; Christian Taube
Journal:  Lab Invest       Date:  2015-11-23       Impact factor: 5.662

3.  Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.

Authors:  Yuxuan Xia; Shaoping Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells.

Authors:  M S Allagui; R Nciri; M F Rouhaud; J C Murat; A El Feki; F Croute; C Vincent
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

5.  Lithium causes G2 arrest of renal principal cells.

Authors:  Theun de Groot; Mohammad Alsady; Marcel Jaklofsky; Irene Otte-Höller; Ruben Baumgarten; Rachel H Giles; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

6.  Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals.

Authors:  Shakila Sabir; Muhammad Furqan Akhtar; Ammara Saleem
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-22       Impact factor: 4.223

7.  Characterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell lines.

Authors:  Hengyun Guan; Pengju Zhang; Chang Liu; Ju Zhang; Zhaoqin Huang; Weiwen Chen; Zhaobo Chen; Nana Ni; Qingwei Liu; Anli Jiang
Journal:  Mol Biol Rep       Date:  2011-03-02       Impact factor: 2.316

8.  Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines.

Authors:  Chunyan Li; Ying Zhang; Yao Lu; Zeshi Cui; Miao Yu; Siyang Zhang; Xiaoxia Xue
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-08       Impact factor: 4.553

9.  GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity.

Authors:  Reena Rao; Satish Patel; Chuanming Hao; James Woodgett; Raymond Harris
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

10.  TCF/beta-catenin plays an important role in HCCR-1 oncogene expression.

Authors:  Goang-Won Cho; Mi-Hwa Kim; Seung Hyun Kim; Seon-Ah Ha; Hyun Kee Kim; Sanghee Kim; Jin W Kim
Journal:  BMC Mol Biol       Date:  2009-05-12       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.